|
|
|
Volumn 56, Issue 6, 2004, Pages 769-780
|
|
Is it possible to improve outcome in patients undergoing surgery for acute limb ischemia? Can iloprost, a prostacyclin analogue, be helpful?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
ILOPROST;
PLACEBO;
VASODILATOR AGENT;
ACUTE DISEASE;
AGED;
ANIMAL;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DISEASE MODEL;
DOUBLE BLIND PROCEDURE;
EMBOLECTOMY;
FEMALE;
FIBRINOLYTIC THERAPY;
FOLLOW UP;
HUMAN;
ISCHEMIA;
LIMB;
MALE;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
PATHOPHYSIOLOGY;
PILOT STUDY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REPERFUSION INJURY;
REVIEW;
THROMBECTOMY;
TIME;
TREATMENT OUTCOME;
VASCULARIZATION;
ACUTE DISEASE;
AGED;
ANIMALS;
DISEASE MODELS, ANIMAL;
DOUBLE-BLIND METHOD;
EMBOLECTOMY;
EXTREMITIES;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
ILOPROST;
ISCHEMIA;
MALE;
MIDDLE AGED;
MULTICENTER STUDIES;
PILOT PROJECTS;
PLACEBOS;
PLATELET AGGREGATION INHIBITORS;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
REPERFUSION INJURY;
THROMBECTOMY;
THROMBOLYTIC THERAPY;
TIME FACTORS;
TREATMENT OUTCOME;
VASODILATOR AGENTS;
|
|
EID: 16244393388
PISSN: 00094773
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (7)
|
|
References (79)
|
